Several immunological and metabolic changes in serum levels from factors such as TNF-α [18], IL-6 [19], plasminogen activator inhibitor (PAI-1) [20], C-reactive protein (CRP) and fibrinogen [21], have been reported to be altered during insulin resistance and adipose tissue inflammation, both consequences of obesity, as well as atherosclerotic plaque formation during dyslipidemias [22, 23]. The gene discussed is CRP; the disease is obesity due to melanocortin 4 receptor deficiency.